BioCentury
ARTICLE | Company News

BTG, Protherics deal

September 22, 2008 7:00 AM UTC

BTG will acquire Protherics in a stock deal that values Protherics at £218.1 million ($393.3 million) or 60p per share. BTG said the deal price is a 46% premium to Protherics' close of 41.25p on Sept. 17, the day before the deal was announced, and a 92% premium to the stock's close of 31.25p on Aug. 12, a day before Protherics issued an announcement regarding potential offers for the company. BTG shareholders will own 59% of the combined company, with Protherics shareholders owing 41%. ...